Erratum: Determining disease intervention strategies using spatially resolved simulations (PLoS ONE (2015) 8:11 (e80506) DOI:10.1371/journal.pone.0080506);Determining disease intervention strategies using spatially resolved simulations

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Read, Mark ^a   Andrews, Paul S ^a   Timmis, Jon ^a   Williams, Richard A ^a   Greaves, Richard B ^a   Sheng, Huiming ^b   Coles, Mark ^a   Kumar, Vipin ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL MURINE MULTIPLE SCLEROSIS SIMULATION; AUTOIMMUNE DISEASE; CALIBRATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELLULAR IMMUNITY; COMPUTER MODEL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SIMULATION; DYNAMICS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOPATHOGENESIS; INFLAMMATORY DISEASE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; METHODOLOGY; MOUSE; MULTIPLE SCLEROSIS; NERVE CELL LESION; NONHUMAN; SIGNAL TRANSDUCTION; STOCHASTIC MODEL; TISSUE SPECIFICITY; TREATMENT PLANNING; ANIMAL; C57BL MOUSE; COMPUTER SIMULATION; DISEASE MODEL; FEMALE; IMMUNOLOGY; METABOLISM; REGULATORY T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; COMPUTER SIMULATION; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY;

EID: 84893597215     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128170     Document Type: Erratum

References (32)

1. Germain RN (2001) The art of the probable: System control in the adaptive immune system. Science 293: 240-245. doi:10.1126/science.1062946. PubMed: 11452112.
2. An G, Mi Q, Dutta-Moscato J, Vodovotz Y (2009) Agent-based models in translational systems biology. Wiley Interdisciplinary Rev Systems Biol Med 1: 159-171. doi:10.1002/wsbm.45. PubMed: 20835989.
3. Read M, Andrews PS, Timmis J, Kumar V (2012) Techniques to ground agent-based simulation in the real domain: a case study in experimental autoimmune encephalomyelitis. Math Computer Modelling Dynamical Systems 18: 67-86. doi:10.1080/13873954.2011.601419.
4. Kumar V, Sercarz E (2001) An integrative model of regulation centered on recognition of TCR peptide/MHC complexes. Immunol Rev 182: 113-121. doi:10.1034/j.1600-065X.2001.1820109.x. PubMed: 11722628. (Pubitemid 33070212)
5. Kumar V (2004) Homeostatic control of immunity by TCR peptide-specific Tregs. J Clin Invest 114: 1222-1226. doi:10.1172/JCI23166. PubMed: 15520851.
6. Bown J, Andrews PS, Deeni Y, Goltsov A, Idowu M et al. (2012) Engineering simulations for cancer systems biology. Curr Drug Targets 13: 1560-1574. doi:10.2174/138945012803530071. PubMed: 22974398.
7. Alden K, Read M, Timmis J, Andrews PS, Veiga-Fernandes H et al. (2013) Spartan: A comprehensive tool for understanding uncertainty in simulations of biological systems. PLOS Comput Biol 9: e1002916. PubMed: 23468606.
8. Beeston T, Smith TRF, Maricic I, Tang X, Kumar V (2010) Involvement of INF-γ and perforin, but not Fas/FasL interactions in regulatory T cell-mediated suppression of experimental autoimmune encephalomyelitis. J Neuroimmunol 229: 91-97. doi:10.1016/j.jneuroim.2010.07.007. PubMed: 20708278.
9. + Treg mediated suppression. Trends Immunol 29: 337-342. doi:10.1016/j.it.2008.04.002. PubMed: 18514574.
10. + T cells. J Immunol 117: 7645-7655.
11. Ben-Nun A, Ron Y, Cohen IR (1980) Spontaneous remission of autoimmune encephalomyelitis is inhibited by splenectomy, thymectomy or ageing. Nature 288: 389-390. doi:10.1038/288389a0. PubMed: 6159555. (Pubitemid 11169017)
12. Chatenoud L, Bluestone JA (2007) CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat Rev Immunol 7: 622-632. doi: 10.1038/nri2134. PubMed: 17641665. (Pubitemid 47123550)
13. Tran GT, Carter N, He XY, Spicer TS, Plain KM et al. (2001) Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on Th1 cells that is augmented by IL-4. Int Immunol 13: 1109-1120. doi:10.1093/intimm/13.9.1109. PubMed: 11526091. (Pubitemid 32899153)
14. Kohm AP, Williams JS, Bickford AL, McMahon JS, Chatenoud L et al. (2005) Treatment with non-mitogenic anti-CD3 monoclonal antibody induces CD4+ T cell unresponsiveness and functional reversal of established experimental autoimmune encephalomyelitis. J Immunol 174: 4525-4534. PubMed: 15814673.
15. Koh DR, Fung-Leung WP, Ho A, Gray D, Acha-Orbea H et al. (1992) Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 256: 1210-1213. doi:10.1126/science.256.5060.1210. PubMed: 1589800.
16. Jiang H, Zhang SI, Pernis B (1992) Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 256: 1213-1215. doi:10.1126/science.256.5060.1213. PubMed: 1375398.
17. Madakamutil LT, Maricic I, Sercarz E, Kumar V (2003) Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes. J Immunol 170: 2985-2992. PubMed: 12626551. (Pubitemid 36302171)
18. Hu D, Ikizawaand K, Lu L, Sanchirico ME, Shinohara ML et al. (2004) Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol 5: 516-523. doi:10.1038/ni1063. PubMed: 15098030. (Pubitemid 38660464)
19. Lindsey JW, Pappolla M, Steinman L (1995) Reinduction of experimental autoimmune encephalomyelitis in mice. Cell Immunol 162: 235-240. doi:10.1006/cimm.1995.1074. PubMed: 7538049.
20. Kumar V, Sercarz EE (1993) The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease. J Exp Med 178: 909-916. doi:10.1084/jem.178.3.909. PubMed: 7688792. (Pubitemid 23260428)
21. - T cells. Eur J Immunol 40: 1906-1915. doi:10.1002/eji.200939608. PubMed: 20394075.
22. Greaves RB, Read M, Timmis J, Andrews PS, Butler JA et al. (2013) In silico investigation of novel biological pathways: the role of CD200 in regulation of T cell priming in Experimental Autoimmune Encephalomyelitis. Biosystems 122: 107-121. PubMed: 23499816.
23. Williams RA, Greaves R, Read M, Timmis J, Andrews P et al. (2013) In silico investigation into dendritic cell regulation of CD8Treg mediated killing of Th1 cells within murine experimental autoimmune encephalomyelitis. BMC Bioinformatics 14: S9. doi:10.1186/1471-2105-14-S15-S9.
24. Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L et al. (2005) Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352: 2598-2608. doi:10.1056/NEJMoa043980. PubMed: 15972866. (Pubitemid 41007846)
25. Sherry N, Hagopian W, Ludvigsson J, Jain SM, Wahlen J et al. (2011) Teplizumab for treatment of type 1 diabetes (protégé study): 1-year results from a randomised, placebo-controlled trial. Lancet 379: 487-497. PubMed: 21719095.
26. GlaxoSmithKline and Tolerx announce phase III DEFEND-1 study of otelixizumab in type 1 diabetes did not meet its primary endpoint; Issued (11th March 2011). Retrieved onpublished at whilst December year 1111 from http://us.gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-10039. htm m (accessed 6th September 2012).
27. Keymeulen B, Walter M, Mathieu C, Kaufman L, Gorus F et al. (2010) Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. Diabetologia 53: 614-623. doi:10.1007/s00125-009-1644-9. PubMed: 20225393.
28. Luke S, Cioffi-Revilla C, Panait L, Sullivan K, Balan G (2005) Mason: A multi-agent simulation environment. Simulation Transactions Soc Modelling Simulation International 82: 517-527.
29. Fowler M (2004) UML Distilled, 3rd edition. Addison-Wesley.
30. Menezes JS, van den Elzen P, Thornes J, Huffman D, Droin NM et al. (2007) A public T cell clonotype within a heterogeneous autoreactive repertoire is dominant in driving EAE. J Clin Invest 117: 2176-2185. doi:10.1172/JCI28277. PubMed: 17627303. (Pubitemid 47219562)
31. Kumar V, Stellrecht K, Sercarz E (1996) Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis. J Exp Med 184: 1609-1617. doi:10.1084/jem.184.5.1609. PubMed: 8920851. (Pubitemid 26404454)
32. Vargha A, Delaney HD (2000) A critique and improvement of the cl common language effect size statistics of McGraw and Wong. J Educ Behav Statist 25: 101-132. doi:10.3102/10769986025002101.